Autoimmune Disorders Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 69 pages | ID: A2F27035599AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Autoimmune Disorders Treatment in Global, including the following market information:

Global Autoimmune Disorders Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Autoimmune Disorders Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bridge Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Autoimmune Disorders Treatment include Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Johnson & Johnson, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Sanofi and Merck and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autoimmune Disorders Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Autoimmune Disorders Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Autoimmune Disorders Treatment Market Segment Percentages, by Type, 2021 (%)

• Bridge Therapy
• Recombinant Technology
• Fecal Bacteriotherapy
• Hematopoietic Stem-cell Transplantation
• Phototherapy
• Helminthic Therapy
• Activation-induced Assays

Global Autoimmune Disorders Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Autoimmune Disorders Treatment Market Segment Percentages, by Application, 2021 (%)

• Systemic Autoimmune Diseases
• Localized Autoimmune Diseases

Global Autoimmune Disorders Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Autoimmune Disorders Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Autoimmune Disorders Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Autoimmune Disorders Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthcare
• Johnson & Johnson
• Boehringer Ingelheim
• GlaxoSmithKline
• AstraZeneca
• Sanofi
• Merck
• Pfizer

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Autoimmune Disorders Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Autoimmune Disorders Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AUTOIMMUNE DISORDERS TREATMENT OVERALL MARKET SIZE

2.1 Global Autoimmune Disorders Treatment Market Size: 2021 VS 2028
2.2 Global Autoimmune Disorders Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Autoimmune Disorders Treatment Players in Global Market
3.2 Top Global Autoimmune Disorders Treatment Companies Ranked by Revenue
3.3 Global Autoimmune Disorders Treatment Revenue by Companies
3.4 Top 3 and Top 5 Autoimmune Disorders Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Autoimmune Disorders Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autoimmune Disorders Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Autoimmune Disorders Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Autoimmune Disorders Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Autoimmune Disorders Treatment Market Size Markets, 2021 & 2028
  4.1.2 Bridge Therapy
  4.1.3 Recombinant Technology
  4.1.4 Fecal Bacteriotherapy
  4.1.5 Hematopoietic Stem-cell Transplantation
  4.1.6 Phototherapy
  4.1.7 Helminthic Therapy
  4.1.8 Activation-induced Assays
4.2 By Type - Global Autoimmune Disorders Treatment Revenue & Forecasts
  4.2.1 By Type - Global Autoimmune Disorders Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Autoimmune Disorders Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Autoimmune Disorders Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Autoimmune Disorders Treatment Market Size, 2021 & 2028
  5.1.2 Systemic Autoimmune Diseases
  5.1.3 Localized Autoimmune Diseases
5.2 By Application - Global Autoimmune Disorders Treatment Revenue & Forecasts
  5.2.1 By Application - Global Autoimmune Disorders Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Autoimmune Disorders Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Autoimmune Disorders Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Autoimmune Disorders Treatment Market Size, 2021 & 2028
6.2 By Region - Global Autoimmune Disorders Treatment Revenue & Forecasts
  6.2.1 By Region - Global Autoimmune Disorders Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Autoimmune Disorders Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Autoimmune Disorders Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Autoimmune Disorders Treatment Revenue, 2017-2028
  6.3.2 US Autoimmune Disorders Treatment Market Size, 2017-2028
  6.3.3 Canada Autoimmune Disorders Treatment Market Size, 2017-2028
  6.3.4 Mexico Autoimmune Disorders Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Autoimmune Disorders Treatment Revenue, 2017-2028
  6.4.2 Germany Autoimmune Disorders Treatment Market Size, 2017-2028
  6.4.3 France Autoimmune Disorders Treatment Market Size, 2017-2028
  6.4.4 U.K. Autoimmune Disorders Treatment Market Size, 2017-2028
  6.4.5 Italy Autoimmune Disorders Treatment Market Size, 2017-2028
  6.4.6 Russia Autoimmune Disorders Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Autoimmune Disorders Treatment Market Size, 2017-2028
  6.4.8 Benelux Autoimmune Disorders Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Autoimmune Disorders Treatment Revenue, 2017-2028
  6.5.2 China Autoimmune Disorders Treatment Market Size, 2017-2028
  6.5.3 Japan Autoimmune Disorders Treatment Market Size, 2017-2028
  6.5.4 South Korea Autoimmune Disorders Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Autoimmune Disorders Treatment Market Size, 2017-2028
  6.5.6 India Autoimmune Disorders Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Autoimmune Disorders Treatment Revenue, 2017-2028
  6.6.2 Brazil Autoimmune Disorders Treatment Market Size, 2017-2028
  6.6.3 Argentina Autoimmune Disorders Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Autoimmune Disorders Treatment Revenue, 2017-2028
  6.7.2 Turkey Autoimmune Disorders Treatment Market Size, 2017-2028
  6.7.3 Israel Autoimmune Disorders Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Autoimmune Disorders Treatment Market Size, 2017-2028
  6.7.5 UAE Autoimmune Disorders Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Autoimmune Disorders Treatment Major Product Offerings
  7.1.4 Abbott Laboratories Autoimmune Disorders Treatment Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Roche Diagnostics
  7.2.1 Roche Diagnostics Corporate Summary
  7.2.2 Roche Diagnostics Business Overview
  7.2.3 Roche Diagnostics Autoimmune Disorders Treatment Major Product Offerings
  7.2.4 Roche Diagnostics Autoimmune Disorders Treatment Revenue in Global Market (2017-2022)
  7.2.5 Roche Diagnostics Key News
7.3 Siemens Healthcare
  7.3.1 Siemens Healthcare Corporate Summary
  7.3.2 Siemens Healthcare Business Overview
  7.3.3 Siemens Healthcare Autoimmune Disorders Treatment Major Product Offerings
  7.3.4 Siemens Healthcare Autoimmune Disorders Treatment Revenue in Global Market (2017-2022)
  7.3.5 Siemens Healthcare Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Autoimmune Disorders Treatment Major Product Offerings
  7.4.4 Johnson & Johnson Autoimmune Disorders Treatment Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Boehringer Ingelheim
  7.5.1 Boehringer Ingelheim Corporate Summary
  7.5.2 Boehringer Ingelheim Business Overview
  7.5.3 Boehringer Ingelheim Autoimmune Disorders Treatment Major Product Offerings
  7.5.4 Boehringer Ingelheim Autoimmune Disorders Treatment Revenue in Global Market (2017-2022)
  7.5.5 Boehringer Ingelheim Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Autoimmune Disorders Treatment Major Product Offerings
  7.6.4 GlaxoSmithKline Autoimmune Disorders Treatment Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Autoimmune Disorders Treatment Major Product Offerings
  7.7.4 AstraZeneca Autoimmune Disorders Treatment Revenue in Global Market (2017-2022)
  7.7.5 AstraZeneca Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Autoimmune Disorders Treatment Major Product Offerings
  7.8.4 Sanofi Autoimmune Disorders Treatment Revenue in Global Market (2017-2022)
  7.8.5 Sanofi Key News
7.9 Merck
  7.9.1 Merck Corporate Summary
  7.9.2 Merck Business Overview
  7.9.3 Merck Autoimmune Disorders Treatment Major Product Offerings
  7.9.4 Merck Autoimmune Disorders Treatment Revenue in Global Market (2017-2022)
  7.9.5 Merck Key News
7.10 Pfizer
  7.10.1 Pfizer Corporate Summary
  7.10.2 Pfizer Business Overview
  7.10.3 Pfizer Autoimmune Disorders Treatment Major Product Offerings
  7.10.4 Pfizer Autoimmune Disorders Treatment Revenue in Global Market (2017-2022)
  7.10.5 Pfizer Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Autoimmune Disorders Treatment Market Opportunities & Trends in Global Market
Table 2. Autoimmune Disorders Treatment Market Drivers in Global Market
Table 3. Autoimmune Disorders Treatment Market Restraints in Global Market
Table 4. Key Players of Autoimmune Disorders Treatment in Global Market
Table 5. Top Autoimmune Disorders Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Autoimmune Disorders Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Autoimmune Disorders Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Autoimmune Disorders Treatment Product Type
Table 9. List of Global Tier 1 Autoimmune Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autoimmune Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Autoimmune Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Autoimmune Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Autoimmune Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Autoimmune Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Autoimmune Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Autoimmune Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Autoimmune Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Autoimmune Disorders Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Autoimmune Disorders Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Autoimmune Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Autoimmune Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Autoimmune Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Autoimmune Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Autoimmune Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Autoimmune Disorders Treatment Product Offerings
Table 32. Abbott Laboratories Autoimmune Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Roche Diagnostics Corporate Summary
Table 34. Roche Diagnostics Autoimmune Disorders Treatment Product Offerings
Table 35. Roche Diagnostics Autoimmune Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Siemens Healthcare Corporate Summary
Table 37. Siemens Healthcare Autoimmune Disorders Treatment Product Offerings
Table 38. Siemens Healthcare Autoimmune Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Autoimmune Disorders Treatment Product Offerings
Table 41. Johnson & Johnson Autoimmune Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Boehringer Ingelheim Corporate Summary
Table 43. Boehringer Ingelheim Autoimmune Disorders Treatment Product Offerings
Table 44. Boehringer Ingelheim Autoimmune Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Autoimmune Disorders Treatment Product Offerings
Table 47. GlaxoSmithKline Autoimmune Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Autoimmune Disorders Treatment Product Offerings
Table 50. AstraZeneca Autoimmune Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Autoimmune Disorders Treatment Product Offerings
Table 53. Sanofi Autoimmune Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Merck Corporate Summary
Table 55. Merck Autoimmune Disorders Treatment Product Offerings
Table 56. Merck Autoimmune Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Pfizer Corporate Summary
Table 58. Pfizer Autoimmune Disorders Treatment Product Offerings
Table 59. Pfizer Autoimmune Disorders Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Autoimmune Disorders Treatment Segment by Type in 2021
Figure 2. Autoimmune Disorders Treatment Segment by Application in 2021
Figure 3. Global Autoimmune Disorders Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Autoimmune Disorders Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Autoimmune Disorders Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autoimmune Disorders Treatment Revenue in 2021
Figure 8. By Type - Global Autoimmune Disorders Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Autoimmune Disorders Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Autoimmune Disorders Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Autoimmune Disorders Treatment Revenue Market Share, 2017-2028
Figure 12. US Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Autoimmune Disorders Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Autoimmune Disorders Treatment Revenue Market Share, 2017-2028
Figure 24. China Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Autoimmune Disorders Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Autoimmune Disorders Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Autoimmune Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Autoimmune Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Diagnostics Autoimmune Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Siemens Healthcare Autoimmune Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Autoimmune Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Boehringer Ingelheim Autoimmune Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Autoimmune Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Autoimmune Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Autoimmune Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merck Autoimmune Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pfizer Autoimmune Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)